1,3-dinitrooxypropan-2-yl nitrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 34 USDMF, 2 CEP/COS, 11 JDMF, 1 KDMF, 4 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

352 FDF Dossiers, 105 FDA Orange Book, 173 Europe, 19 Canada, 10 Australia, 4 South Africa, 41 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;SUBLINGUAL - 0.4MG/SPRAY, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.1MG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.2MG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.3MG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.4MG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.6MG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.8MG/HR, POWDER;SUBLINGUAL - 0.4MG/PACKET, TABLET;SUBLINGUAL - 0.3MG, TABLET;SUBLINGUAL - 0.4MG, TABLET;SUBLINGUAL - 0.6MG, OINTMENT;INTRA-ANAL - 0.4%, AEROSOL, METERED;SUBLINGUAL - 0.4MG/SPRAY, OINTMENT;TRANSDERMAL - 2%

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 18 SPI Pharma, 12 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 8 Beneo, 6 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 29 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 18 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 31 Roquette, 2 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

99 Fillers, Diluents & Binders, 44 Direct Compression, 32 Taste Masking, 25 Thickeners and Stabilizers, 25 Coating Systems & Additives, 23 Granulation, 23 Lubricants & Glidants, 21 Film Formers & Plasticizers, 18 Co-Processed Excipients, 18 Disintegrants & Superdisintegrants, 17 Parenteral, 16 Chewable & Orodispersible Aids, 14 Topical, 12 Controlled & Modified Release, 9 Solubilizers, 8 Empty Capsules, 5 Emulsifying Agents, 4 Rheology Modifiers, 3 API Stability Enhancers, 3 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 23 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 177 Finished Drug Prices, 2 Annual Reports

MARKET PLACE

27 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 1 US Exclusivities, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21134 / DOSAGE - TABLET;SUBLINGUAL - 0.3MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
NITROGLYCERIN(UNII: G59M7S0WS3) (NITROGLYCERIN - UNII:G59M7S0WS3)	NITROGLYCERIN	0.4mg

Inactive Ingredients

Ingredient Name	A-S Medication Solutions LLC	Bryant Ranch Prepack	General Injectables & Vaccines, Inc	Ingenus Pharmaceuticals NJ, LLC	NuCare Pharmaceuticals,Inc.	Preferred Pharmaceuticals Inc.	Preferred Pharmaceuticals, Inc.	REMEDYREPACK INC.
CALCIUM STEARATE(776XM7047L)
CROSCARMELLOSE SODIUM(M28OL1HH48)
GLYCERYL MONOSTEARATE(230OU9XXE4)
HYDROGENATED COTTONSEED OIL(Z82Y2C65EA)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
SILICA DIMETHYL SILYLATE(EU2PSP0G0W)
SILICON DIOXIDE(ETJ7Z6XBU4)
STARCH, CORN(O8232NY3SJ)

Drug Product Composition: 1,3-dinitrooxypropan-2-yl nitrate